Inquiry list (0)
Meeting Us
iSRS 2025
Meet us in Gold Coast, Australia, May 11-15, #8
Solutions for Radiochemicals
We are pleased to offer a broad selection of PET and SPECT precursors, reference standards, reagent kits and consumables. Our products have been developed for the production of 18F ,11C , 68Ga , 177Lu tracers, with the mainstream synthesis modules
Products and Services
Years of Experience
RTU Kits Developed
Global Clients
Employees
Huayi Isotopes Achieves FDA DMF Acceptance for DOTATATE ACETATE
Huayi Isotopes, a subsidiary of Huayi Technology Co., Ltd., has received a Drug Master File (DMF) acceptance letter from the U.S. Food and Drug Administration (FDA) for its DOTATATE ACETATE (DMF No. 041558), a peptide-based precursor for radiopharmaceuticals.
Huayi Pharmaceutical (Guangdong) Co., Ltd. Obtains Radioactive Pharmaceutical Production License
Huayi Pharmaceutical (Guangdong) Co., Ltd. successfully obtained the “Radioactive Pharmaceutical Production License” issued by the National Medical Products Administration.
HIC at 2025 ALASBIMN: Exploring Frontiers in Nuclear Medicine & Molecular Imaging
Huayi Highlights Full Industrial Chain Expertise at EANM 2024 : Advancing Nuclear Medicine Together
Huayi Celebrates Milestone Achievement with DMF Registration for PSMA-11 Precursor
We proudly announces a significant milestone with the successful acquisition of Drug Master File (DMF) registration for the PSMA-11 precursor. This achievement underscores Huayi's unwavering commitment to upholding the highest standards in the development and production of radiopharmaceuticals.